M. Mukherjee (Hamilton (ON), Canada), A. Bossios (Stockholm, Sweden)
Introduction
M. Mukherjee (Hamilton (ON), Canada), A. Bossios (Stockholm, Sweden)
|  |
Efficacy of tezepelumab in patients with severe, uncontrolled asthma and low blood eosinophil counts not receiving maintenance oral corticosteroids
A. Menzies-Gow (London, United Kingdom), B. Cook (Gaithersburg, MD, United States), G. Colice (Gaithersburg, MD, United States), Å. Hellqvist (Gothenburg, Sweden), J. Llanos-Ackert (Thousand Oaks, CA, United States), C. Ambrose (Gaithersburg, MD, United States)
|    |
Prevalence and impact of hypereosinophilia in severe asthma treated by dupilumab: an observational analysis
S. Everaerts (Leuven, Belgium), B. Hilvering (Amsterdam, Netherlands), E. Weersink (Amsterdam, Netherlands)
| |
Dupilumab improved lung function and reduces exacerbations in patients with 1, 2, or 3 prior exacerbations: TRAVERSE
J. Corren (Los Angeles, CA, United States), M. Castro (Kansas City, KS, United States), J. Maspero (Buenos Aires, Argentina), M. Humbert (Le Kremlin-Bicêtre, France), D. Halpin (Exeter, United Kingdom), A. Altincatal (Cambridge, MA, United States), N. Pandit-Abid (Bridgewater, NJ, United States), X. Soler (Tarrytown, NY, United States), S. Siddiqui (Tarrytown, NY, United States), J. Jacob-Nara (Bridgewater, NJ, United States), Y. Deniz (Tarrytown, NY, United States), P. Rowe (Bridgewater, NJ, United States), J. Maspero (Ciudad Autónoma Buenos Aires, Argentina)
| |
Benralizumab attenuates blood and airway eosinophilia in severe asthmatics with inadequate response to anti-IL-5 neutralizing antibodies
M. Mukherjee (Hamilton (ON), Canada), A. Bhalla (Hamilton (ON), Canada), C. Venegas-Garrido (Hamilton (ON), Canada), C. Huang (Hamilton (ON), Canada), K. Radford (Hamilton (ON), Canada), M. Kjarsgaard (Hamilton (ON), Canada), S. Lauks (Hamilton (ON), Canada), K. Son (Hamilton (ON), Canada), N. Lavigne (Hamilton (ON), Canada), R. Sehmi (Hamilton (ON), Canada), P. O'Byrne (Hamilton (ON), Canada), P. Nair (Hamilton (ON), Canada)
| |
Past smoking does not influence response to biologic therapy in patients with severe asthma
M. Rahman (Southampton, United Kingdom), P. Dennison (Southampton, United Kingdom), A. Azim (Southampton, United Kingdom), A. Freeman (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), H. Rupani (Southampton, United Kingdom)
| |
Relation between reduction in fractional exhaled nitric oxide and efficacy in asthma patients treated with dupilumab
I. Pavord (Oxford (Oxfordshire), United Kingdom), Y. Deniz (Tarrytown, NY, United States), T. Casale (Tampa, FL, United States), J. Corren (Los Angeles, CA, United States), M. Fitzgerald (Vancouver, BC, Canada), N. Daizadeh (Cambridge, MA, United States), A. Jagerschmidt (Chilly-Mazarin, France), M. Dillon (Tarrytown, NY, United States), R. Gall (Tarrytown, NY, United States), N. Pandit-Abid (Bridjewater, NJ, United States), S. Siddiqui (Tarrytown, NY, United States), J. Jacob-Nara (Bridjewater, NJ, United States), P. Rowe (Bridjewater, NJ, United States), W. Busse (Madison, WI, United States)
| |
On-treatment clinical remission with tezepelumab among patients with severe, uncontrolled asthma in the phase 3 NAVIGATOR study
M. Castro (Kansas City, United States), C. Ambrose (Gaithersburg, United States), G. Colice (Gaithersburg, United States), S. Roseti (Gaithersburg, United States), K. Kmita (Warsaw, Poland), B. Cook (Gaithersburg, United States), N. Martin (Leicester, United Kingdom), J. Llanos-Ackert (California, United States), A. Menzies-Gow (London, United Kingdom)
| |
Clinical response and remission in patients with severe asthma treated with biologic treatment: Findings from the nationwide Danish Severe Asthma Registry
S. Hansen (Copenhagen, Denmark), A. Von Buelow (Copenhagen, Denmark), M. Soendergaard (Copenhagen, Denmark), L. Rasmussen (Copenhagen, Denmark), C. Johnsen (Copenhagen, Denmark), T. Ingebrigtsen (Copenhagen, Denmark), K. Haakansson (Copenhagen, Denmark), K. Assing (Copenhagen, Denmark), S. Johansson (Copenhagen, Denmark), J. Schmid (Copenhagen, Denmark), A. Bjerrum (Copenhagen, Denmark), O. Hilberg (Copenhagen, Denmark), C. Ulrik (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
| |
Effect of tezepelumab on a composite of severe asthma exacerbations and acute worsening events, CompEx, in the phase 3 NAVIGATOR study
G. Brusselle (Ghent, Belgium), N. Martin (Leicester, United Kingdom), S. Ponnarambil (Cambridge, United Kingdom), G. Hunter (Cambridge, United Kingdom), Å. Hellqvist (Gothenburg, Sweden), M. Fagerås (Gothenburg, Sweden), C. Da Silva (Gothenburg, Sweden)
| |
Late Breaking Abstract - Mepolizumab effectiveness in severe asthma supported by federated analysis of European SHARP data
J. Kroes (Leeuwarden, Netherlands), R. Alfonso-Cristancho (Brentford, United Kingdom), A. Bansal (Cambridge, United Kingdom), E. Berret (Lausanne, Switzerland), K. Bieksiene (Kaunas, Lithuania), A. Bourdin (Montpellier, France), L. Brussino (Turin, Italy), D. Canhoto (Coimbra, Portugal), C. Cardini (Milan, Italy), G. Celik (Ankara, Turkey), Z. Csoma (Budapest, Hungary), B. Dahlén (Stockholm, Sweden), E. Damadoglu (Ankara, Turkey), K. Eger (Amsterdam, Netherlands), L. Gauquelin (Paris, France), B. Gemicioglu (Istanbul, Turkey), O. Goksel (Izmir, Turkey), S. Graff (Liege, Belgium), E. Heffler (Rozzano MI, Italy), H. Hofstee (Leiden, Netherlands), P. Howarth (Brentford, United Kingdom), R. Jakes (Brentford, United Kingdom), F. Jaun (Liestal, Switzerland), V. Kalinauskaite-Zukauske (Kaunas, Lithuania), P. Kopac (Golnik, Slovenia), N. Kwon (Brentford, United Kingdom), C. Loureiro (Coimbra, Portugal), V. Lozoya García (Madrid, Spain), M. Masoli (Exeter, United Kingdom), M. Paula Rezelj (Golnik, Slovenia), L. Pérez De Llano (Lugo, Spain), S. Popovic-Grle (Zagreb, Croatia), D. Ramos-Barbon (Barcelona, Spain), A. Sà Sousa (Porto, Portugal), K. Samitas (Athens, Greece), F. Schleich (Liege, Belgium), C. Sirena (Milan, Italy), S. Skrgat (Ljubljana, Slovenia), E. Zervas (Athens, Greece), G. Zichnalis (Athens, Greece), E. Bel (Amsterdam, Netherlands), J. Sont (Leiden, Netherlands), S. Hashimoto (Amsterdam, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands)
| |